Noticias de CRDF_US

Noticias del mercado

Últimas noticias sobre CRDF_US — 125 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: CRDF_US ✕ 125 resultados
22/04/2026 CRDF_US — laocai.gov.vn
CRDF (Cardiff Oncology Inc.) reports narrower than expected Q4 2025 loss, shares climb 4.29% on positive investor sentiment. - Buyback Report
22/04/2026 CRDF_US — news.google.com
CRDF (Cardiff Oncology Inc.) reports narrower than expected Q4 2025 loss, shares climb 4.29% on positive investor sentiment. - Hold Rating
22/04/2026 CRDF_US — Investing.com Nigeria
Cardiff Oncology to present colorectal cancer trial data at ASCO By Investing.com
22/04/2026 CRDF_US — Investing.com ES ← EN
Cardiff Oncology presentará datos de ensayos sobre cáncer colorrectal en ASCO Por Investing.com

Cardiff Oncology to present colorectal cancer trial data at ASCO By Investing.com

21/04/2026 CRDF_US — Investing.com
Cardiff Oncology to present colorectal cancer trial data at ASCO By Investing.com
21/04/2026 CRDF_US — Investing.com ES ← EN
Cardiff Oncology presentará datos de ensayos sobre cáncer colorrectal en ASCO Por Investing.com

Cardiff Oncology to present colorectal cancer trial data at ASCO By Investing.com

21/04/2026 CRDF_US — Investing.com ES ← EN
Cardiff Oncology presentará datos de ensayos sobre cáncer colorrectal en ASCO Por Investing.com

Cardiff Oncology to present colorectal cancer trial data at ASCO By Investing.com

21/04/2026 CRDF_US — MarketBeat ES ← EN
Cardiff Oncology, Inc. (NASDAQ:CRDF) recibió una recomendación promedio de "compra moderada" por parte de los analistas

Cardiff Oncology, Inc. (NASDAQ:CRDF) Given Average Recommendation of "Moderate Buy" by Analysts

21/04/2026 CRDF_US — GlobeNewswire
Cardiff Oncology to Present Updated Phase 2 Data of
21/04/2026 CRDF_US — Stock Titan
Updated metastatic colon cancer data gets ASCO oral slot
21/04/2026 CRDF_US — Quiver Quantitative
Cardiff Oncology to Present Updated Data on Onvansertib in RAS-Mutated Colorectal Cancer at ASCO 2026
21/04/2026 CRDF_US — Investing.com
Cardiff Oncology to present colorectal cancer trial data at ASCO
21/04/2026 CRDF_US — Yahoo Finance
Cardiff Oncology to Present Updated Phase 2 Data of Onvansertib in First-Line RAS-Mutated mCRC in a Rapid Oral Session at ASCO 2026
21/04/2026 CRDF_US — MarketBeat
Cardiff Oncology (NASDAQ:CRDF) Trading Down 1.1% - Here's What Happened
21/04/2026 CRDF_US — Investing.com
Cardiff Oncology to present colorectal cancer trial data at ASCO By Investing.com
18/04/2026 CRDF_US — MSN
Cardiff Oncology (CRDF) price target decreased by 17.38% to 8.74
18/04/2026 CRDF_US — Sahm ES ← EN
Cardiff Oncology presenta datos preclínicos sobre su inhibidor de PLK1 Onvansertib en combinación con un ADC dirigido a HER2 en la reunión anual de la AACR de 2026
18/04/2026 CRDF_US — Investing.com
Cardiff Oncology presents preclinical data on cancer drug combo By Investing.com
18/04/2026 CRDF_US — Investing.com
Cardiff Oncology presents preclinical data on cancer drug combo By Investing.com
18/04/2026 CRDF_US — GuruFocus
Cardiff Oncology (CRDF) Unveils Promising Preclinical Data at AA

Página 3 de 7

keyboard_arrow_up